Publication:
Effects of agmatine on Akt/GSK-3beta/betacatenin signaling pathway in SH-SY5Y cell culture: Relevance to schizophrenia

Simple item page
dc.contributor.authorARICIOĞLU, FEYZA
dc.contributor.authorsUnal, G.; Aricioglu, F.; Dokumaci, A. H.; Yerer-Aycan, M. B.; Ozkartal-Sahin, C.
dc.date.accessioned2022-03-12T16:24:16Z
dc.date.accessioned2026-01-11T07:16:04Z
dc.date.available2022-03-12T16:24:16Z
dc.date.issued2019
dc.identifier.doi10.1016/j.euroneuro.2019.01.023
dc.identifier.eissn1873-7862
dc.identifier.issn0924-977X
dc.identifier.urihttps://hdl.handle.net/11424/226279
dc.identifier.wosWOS:000458144500023
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofEUROPEAN NEUROPSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEffects of agmatine on Akt/GSK-3beta/betacatenin signaling pathway in SH-SY5Y cell culture: Relevance to schizophrenia
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS648
oaire.citation.startPageS647
oaire.citation.titleEUROPEAN NEUROPSYCHOPHARMACOLOGY
oaire.citation.volume29

Files

Collections

Araştırma Çıktıları